<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-11-01" modified="2020-10-07" version="216">
<accession>P18507</accession>
<accession>F5HB82</accession>
<accession>Q6GRL6</accession>
<accession>Q6PCC3</accession>
<accession>Q9UDB3</accession>
<accession>Q9UN15</accession>
<name>GBRG2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Gamma-aminobutyric acid receptor subunit gamma-2</fullName>
</recommendedName>
<alternativeName>
<fullName>GABA(A) receptor subunit gamma-2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GABRG2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Nature" volume="338" first="582" last="585">
<title>Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.</title>
<authorList>
<person name="Pritchett D.B."/>
<person name="Sontheimer H."/>
<person name="Shivers B.D."/>
<person name="Ymer S."/>
<person name="Kettenmann H."/>
<person name="Schofield P.R."/>
<person name="Seeburg P.H."/>
</authorList>
<dbReference type="PubMed" id="2538761"/>
<dbReference type="DOI" id="10.1038/338582a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>ACTIVITY REGULATION</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="DNA Seq." volume="11" first="373" last="382">
<title>Complete genomic sequence of 195 Kb of human DNA containing the gene GABRG2.</title>
<authorList>
<person name="Jiang S."/>
<person name="Yu J."/>
<person name="Wang J."/>
<person name="Tan Z."/>
<person name="Xue H."/>
<person name="Feng G."/>
<person name="He L."/>
<person name="Yang H."/>
</authorList>
<dbReference type="PubMed" id="11328646"/>
<dbReference type="DOI" id="10.3109/10425170009033988"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT ARG-357</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="J. Neurochem." volume="60" first="961" last="971">
<title>Antibodies to the human gamma 2 subunit of the gamma-aminobutyric acidA/benzodiazepine receptor.</title>
<authorList>
<person name="Khan Z.U."/>
<person name="Fernando L.P."/>
<person name="Escriba P."/>
<person name="Busquets X."/>
<person name="Mallet J."/>
<person name="Miralles C.P."/>
<person name="Filla M."/>
<person name="De Blas A.L."/>
</authorList>
<dbReference type="PubMed" id="8382267"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.1993.tb03243.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 357-443 (ISOFORM 1)</scope>
<source>
<tissue>Brain cortex</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Nature" volume="397" first="69" last="72">
<title>GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton.</title>
<authorList>
<person name="Wang H."/>
<person name="Bedford F.K."/>
<person name="Brandon N.J."/>
<person name="Moss S.J."/>
<person name="Olsen R.W."/>
</authorList>
<dbReference type="PubMed" id="9892355"/>
<dbReference type="DOI" id="10.1038/16264"/>
</citation>
<scope>INTERACTION WITH GABARAP</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2013" name="Eur. J. Neurosci." volume="38" first="3146" last="3158">
<title>GABA(A) receptors can initiate the formation of functional inhibitory GABAergic synapses.</title>
<authorList>
<person name="Fuchs C."/>
<person name="Abitbol K."/>
<person name="Burden J.J."/>
<person name="Mercer A."/>
<person name="Brown L."/>
<person name="Iball J."/>
<person name="Anne Stephenson F."/>
<person name="Thomson A.M."/>
<person name="Jovanovic J.N."/>
</authorList>
<dbReference type="PubMed" id="23909897"/>
<dbReference type="DOI" id="10.1111/ejn.12331"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2014" name="J. Vis. Exp." volume="2014" first="E52115" last="E52115">
<title>Inhibitory synapse formation in a co-culture model incorporating GABAergic medium spiny neurons and HEK293 cells stably expressing GABAA receptors.</title>
<authorList>
<person name="Brown L.E."/>
<person name="Fuchs C."/>
<person name="Nicholson M.W."/>
<person name="Stephenson F.A."/>
<person name="Thomson A.M."/>
<person name="Jovanovic J.N."/>
</authorList>
<dbReference type="PubMed" id="25489750"/>
<dbReference type="DOI" id="10.3791/52115"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2017" name="Brain" volume="140" first="49" last="67">
<title>De novo GABRG2 mutations associated with epileptic encephalopathies.</title>
<authorList>
<person name="Shen D."/>
<person name="Hernandez C.C."/>
<person name="Shen W."/>
<person name="Hu N."/>
<person name="Poduri A."/>
<person name="Shiedley B."/>
<person name="Rotenberg A."/>
<person name="Datta A.N."/>
<person name="Leiz S."/>
<person name="Patzer S."/>
<person name="Boor R."/>
<person name="Ramsey K."/>
<person name="Goldberg E."/>
<person name="Helbig I."/>
<person name="Ortiz-Gonzalez X.R."/>
<person name="Lemke J.R."/>
<person name="Marsh E.D."/>
<person name="Macdonald R.L."/>
</authorList>
<dbReference type="PubMed" id="27864268"/>
<dbReference type="DOI" id="10.1093/brain/aww272"/>
</citation>
<scope>VARIANTS EIEE74 THR-106; THR-107; SER-282; GLN-323; TRP-323 AND LEU-343</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE74 THR-106; THR-107; SER-282; GLN-323; TRP-323 AND LEU-343</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="10" evidence="1 2">
<citation type="journal article" date="2018" name="Nature" volume="559" first="67" last="72">
<title>Structure of a human synaptic GABAA receptor.</title>
<authorList>
<person name="Zhu S."/>
<person name="Noviello C.M."/>
<person name="Teng J."/>
<person name="Walsh R.M. Jr."/>
<person name="Kim J.J."/>
<person name="Hibbs R.E."/>
</authorList>
<dbReference type="PubMed" id="29950725"/>
<dbReference type="DOI" id="10.1038/s41586-018-0255-3"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.80 ANGSTROMS) OF 8-326 IN COMPLEX WITH GABA AND FLUMAZENIL</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Nat. Genet." volume="28" first="46" last="48">
<title>First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.</title>
<authorList>
<person name="Baulac S."/>
<person name="Huberfeld G."/>
<person name="Gourfinkel-An I."/>
<person name="Mitropoulou G."/>
<person name="Beranger A."/>
<person name="Prud'homme J.-F."/>
<person name="Baulac M."/>
<person name="Brice A."/>
<person name="Bruzzone R."/>
<person name="LeGuern E."/>
</authorList>
<dbReference type="PubMed" id="11326274"/>
<dbReference type="DOI" id="10.1038/ng0501-46"/>
</citation>
<scope>VARIANT GEFS+3 MET-328</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Nat. Genet." volume="28" first="49" last="52">
<title>Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.</title>
<authorList>
<person name="Wallace R.H."/>
<person name="Marini C."/>
<person name="Petrou S."/>
<person name="Harkin L.A."/>
<person name="Bowser D.N."/>
<person name="Panchal R.G."/>
<person name="Williams D.A."/>
<person name="Sutherland G.R."/>
<person name="Mulley J.C."/>
<person name="Scheffer I.E."/>
<person name="Berkovic S.F."/>
</authorList>
<dbReference type="PubMed" id="11326275"/>
<dbReference type="DOI" id="10.1038/ng0501-49"/>
</citation>
<scope>VARIANT ECA2/FEB8 GLN-82</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Neurology" volume="67" first="687" last="690">
<title>A novel GABRG2 mutation associated with febrile seizures.</title>
<authorList>
<person name="Audenaert D."/>
<person name="Schwartz E."/>
<person name="Claeys K.G."/>
<person name="Claes L."/>
<person name="Deprez L."/>
<person name="Suls A."/>
<person name="Van Dyck T."/>
<person name="Lagae L."/>
<person name="Van Broeckhoven C."/>
<person name="Macdonald R.L."/>
<person name="De Jonghe P."/>
</authorList>
<dbReference type="PubMed" id="16924025"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000230145.73496.a2"/>
</citation>
<scope>VARIANT FEB8 GLY-177</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="J. Hum. Genet." volume="55" first="375" last="378">
<title>Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies.</title>
<authorList>
<person name="Shi X."/>
<person name="Huang M.C."/>
<person name="Ishii A."/>
<person name="Yoshida S."/>
<person name="Okada M."/>
<person name="Morita K."/>
<person name="Nagafuji H."/>
<person name="Yasumoto S."/>
<person name="Kaneko S."/>
<person name="Kojima T."/>
<person name="Hirose S."/>
</authorList>
<dbReference type="PubMed" id="20485450"/>
<dbReference type="DOI" id="10.1038/jhg.2010.47"/>
</citation>
<scope>VARIANT SER-79</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Eur. J. Neurosci." volume="34" first="237" last="249">
<title>Novel alpha1 and gamma2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy.</title>
<authorList>
<person name="Lachance-Touchette P."/>
<person name="Brown P."/>
<person name="Meloche C."/>
<person name="Kinirons P."/>
<person name="Lapointe L."/>
<person name="Lacasse H."/>
<person name="Lortie A."/>
<person name="Carmant L."/>
<person name="Bedford F."/>
<person name="Bowie D."/>
<person name="Cossette P."/>
</authorList>
<dbReference type="PubMed" id="21714819"/>
<dbReference type="DOI" id="10.1111/j.1460-9568.2011.07767.x"/>
</citation>
<scope>VARIANT SER-83</scope>
<scope>CHARACTERIZATION OF VARIANT SER-83</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="825" last="830">
<title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.</title>
<authorList>
<person name="Carvill G.L."/>
<person name="Heavin S.B."/>
<person name="Yendle S.C."/>
<person name="McMahon J.M."/>
<person name="O'Roak B.J."/>
<person name="Cook J."/>
<person name="Khan A."/>
<person name="Dorschner M.O."/>
<person name="Weaver M."/>
<person name="Calvert S."/>
<person name="Malone S."/>
<person name="Wallace G."/>
<person name="Stanley T."/>
<person name="Bye A.M."/>
<person name="Bleasel A."/>
<person name="Howell K.B."/>
<person name="Kivity S."/>
<person name="Mackay M.T."/>
<person name="Rodriguez-Casero V."/>
<person name="Webster R."/>
<person name="Korczyn A."/>
<person name="Afawi Z."/>
<person name="Zelnick N."/>
<person name="Lerman-Sagie T."/>
<person name="Lev D."/>
<person name="Moeller R.S."/>
<person name="Gill D."/>
<person name="Andrade D.M."/>
<person name="Freeman J.L."/>
<person name="Sadleir L.G."/>
<person name="Shendure J."/>
<person name="Berkovic S.F."/>
<person name="Scheffer I.E."/>
<person name="Mefford H.C."/>
</authorList>
<dbReference type="PubMed" id="23708187"/>
<dbReference type="DOI" id="10.1038/ng.2646"/>
</citation>
<scope>VARIANT GEFS+3 GLN-323</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="216" last="225">
<title>Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes.</title>
<authorList>
<consortium name="Clinical Study Group"/>
<person name="Parrini E."/>
<person name="Marini C."/>
<person name="Mei D."/>
<person name="Galuppi A."/>
<person name="Cellini E."/>
<person name="Pucatti D."/>
<person name="Chiti L."/>
<person name="Rutigliano D."/>
<person name="Bianchini C."/>
<person name="Virdo S."/>
<person name="De Vita D."/>
<person name="Bigoni S."/>
<person name="Barba C."/>
<person name="Mari F."/>
<person name="Montomoli M."/>
<person name="Pisano T."/>
<person name="Rosati A."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="27864847"/>
<dbReference type="DOI" id="10.1002/humu.23149"/>
</citation>
<scope>VARIANT CYS-274</scope>
</reference>
<comment type="function">
<text evidence="8 17 18 19 20 22">Ligand-gated chloride channel which is a component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the brain (PubMed:2538761, PubMed:29950725). Plays an important role in the formation of functional inhibitory GABAergic synapses in addition to mediating synaptic inhibition as a GABA-gated ion channel (PubMed:23909897, PubMed:25489750, PubMed:27864268). The gamma2 subunit is necessary but not sufficient for a rapid formation of active synaptic contacts and the synaptogenic effect of this subunit is influenced by the type of alpha and beta subunits present in the receptor pentamer (By similarity). The alpha1/beta2/gamma2 receptor and the alpha1/beta3/gamma2 receptor exhibit synaptogenic activity (PubMed:23909897, PubMed:25489750). The alpha2/beta2/gamma2 receptor exhibits synatogenic activity whereas the alpha2/beta3/gamma2 receptor shows very little or no synaptogenic activity (By similarity). Functions also as histamine receptor and mediates cellular responses to histamine (By similarity).</text>
</comment>
<comment type="activity regulation">
<text evidence="7 18 20 22">Allosterically activated by benzodiazepines (PubMed:2538761, PubMed:29950725). Activated by pentobarbitol (By similarity). Inhibited by the antagonist bicuculline (PubMed:29950725). Inhibited by zinc ions (PubMed:27864268).</text>
</comment>
<comment type="subunit">
<text evidence="7 8 18 22 23">Heteropentamer, formed by a combination of alpha, beta, gamma, delta and rho chains (PubMed:2538761, PubMed:29950725). Interacts with GABARAP (PubMed:9892355). Interacts with KIF21B (By similarity). Identified in a complex of 720 kDa composed of LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2 and GABRB3 (By similarity). Interacts with LHFPL4 (By similarity). Interacts with SHISA7; interaction leads to the regulation of GABA(A) receptor trafficking, channel deactivation kinetics and pharmacology (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9008430">
<id>P18507</id>
</interactant>
<interactant intactId="EBI-726123">
<id>P51513</id>
<label>NOVA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15096952">
<id>P18507-2</id>
</interactant>
<interactant intactId="EBI-712001">
<id>O95166</id>
<label>GABARAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="18">Cell junction</location>
<location evidence="18">Synapse</location>
<location evidence="18">Postsynaptic cell membrane</location>
<topology evidence="9">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="18 20">Cell membrane</location>
<topology evidence="9">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Cell projection</location>
<location evidence="8">Dendrite</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Cytoplasmic vesicle membrane</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P18507-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P18507-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041124"/>
</isoform>
<isoform>
<id>P18507-3</id>
<name>3</name>
<sequence type="described" ref="VSP_047323 VSP_041124"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="8">The extracellular domain contributes to synaptic contact formation.</text>
</comment>
<comment type="PTM">
<text evidence="8">Glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="8">Palmitoylated by ZDHHC3/GODZ; required for the accumulation of GABA(A) receptors at the postsynaptic membrane of inhibitory GABAergic synapses.</text>
</comment>
<comment type="disease" evidence="20">
<disease id="DI-05528">
<name>Epileptic encephalopathy, early infantile, 74</name>
<acronym>EIEE74</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE74 is an autosomal dominant form with onset in the first year of life.</description>
<dbReference type="MIM" id="618396"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="11">
<disease id="DI-00297">
<name>Epilepsy, childhood absence 2</name>
<acronym>ECA2</acronym>
<description>A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Some individuals manifest febrile seizures. Absence seizures may either remit or persist into adulthood.</description>
<dbReference type="MIM" id="607681"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-00490">
<name>Febrile seizures, familial, 8</name>
<acronym>FEB8</acronym>
<description>Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy.</description>
<dbReference type="MIM" id="607681"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="10 16">
<disease id="DI-00507">
<name>Generalized epilepsy with febrile seizures plus 3</name>
<acronym>GEFS+3</acronym>
<description>A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.</description>
<dbReference type="MIM" id="607681"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>This subunit carries the benzodiazepine binding site.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the ligand-gated ion channel (TC 1.A.9) family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily. GABRG2 sub-subfamily.</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/056"/>
<text>Forbidden fruit - Issue 56 of March 2005</text>
</comment>
<dbReference type="EMBL" id="X15376">
<property type="protein sequence ID" value="CAA33437.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF165124">
<property type="protein sequence ID" value="AAD50273.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008611">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC091926">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC091984">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC059389">
<property type="protein sequence ID" value="AAH59389.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC069348">
<property type="protein sequence ID" value="AAH69348.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC074795">
<property type="protein sequence ID" value="AAH74795.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4358.1">
<molecule id="P18507-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4359.1">
<molecule id="P18507-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47333.1">
<molecule id="P18507-3"/>
</dbReference>
<dbReference type="PIR" id="S03905">
<property type="entry name" value="S03905"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000807.2">
<molecule id="P18507-1"/>
<property type="nucleotide sequence ID" value="NM_000816.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_944493.2">
<molecule id="P18507-3"/>
<property type="nucleotide sequence ID" value="NM_198903.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_944494.1">
<molecule id="P18507-2"/>
<property type="nucleotide sequence ID" value="NM_198904.2"/>
</dbReference>
<dbReference type="PDB" id="6D6T">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="E=8-326"/>
</dbReference>
<dbReference type="PDB" id="6D6U">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="E=40-361, E=439-467"/>
</dbReference>
<dbReference type="PDB" id="6HUG">
<property type="method" value="EM"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="C=1-467"/>
</dbReference>
<dbReference type="PDB" id="6HUJ">
<property type="method" value="EM"/>
<property type="resolution" value="3.04"/>
<property type="chains" value="C=1-467"/>
</dbReference>
<dbReference type="PDB" id="6HUK">
<property type="method" value="EM"/>
<property type="resolution" value="3.69"/>
<property type="chains" value="C=1-467"/>
</dbReference>
<dbReference type="PDB" id="6HUO">
<property type="method" value="EM"/>
<property type="resolution" value="3.26"/>
<property type="chains" value="C=1-467"/>
</dbReference>
<dbReference type="PDB" id="6HUP">
<property type="method" value="EM"/>
<property type="resolution" value="3.58"/>
<property type="chains" value="C=1-467"/>
</dbReference>
<dbReference type="PDB" id="6I53">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="C=1-467"/>
</dbReference>
<dbReference type="PDBsum" id="6D6T"/>
<dbReference type="PDBsum" id="6D6U"/>
<dbReference type="PDBsum" id="6HUG"/>
<dbReference type="PDBsum" id="6HUJ"/>
<dbReference type="PDBsum" id="6HUK"/>
<dbReference type="PDBsum" id="6HUO"/>
<dbReference type="PDBsum" id="6HUP"/>
<dbReference type="PDBsum" id="6I53"/>
<dbReference type="SMR" id="P18507"/>
<dbReference type="BioGRID" id="108840">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2159">
<property type="entry name" value="GABA-A receptor, alpha-1/beta-2/gamma-2"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2164">
<property type="entry name" value="GABA-A receptor, alpha-6/beta-3/gamma-2"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2166">
<property type="entry name" value="GABA-A receptor, alpha-3/beta-3/gamma-2"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2167">
<property type="entry name" value="GABA-A receptor, alpha-1/beta-3/gamma-2"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2168">
<property type="entry name" value="GABA-A receptor, alpha-5/beta-3/gamma-2"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2174">
<property type="entry name" value="GABA-A receptor, alpha-2/beta-3/gamma-2"/>
</dbReference>
<dbReference type="CORUM" id="P18507"/>
<dbReference type="IntAct" id="P18507">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="P18507"/>
<dbReference type="STRING" id="9606.ENSP00000410732"/>
<dbReference type="BindingDB" id="P18507"/>
<dbReference type="ChEMBL" id="CHEMBL2094120"/>
<dbReference type="ChEMBL" id="CHEMBL2094121"/>
<dbReference type="ChEMBL" id="CHEMBL2094122"/>
<dbReference type="ChEMBL" id="CHEMBL2094130"/>
<dbReference type="ChEMBL" id="CHEMBL2095172"/>
<dbReference type="ChEMBL" id="CHEMBL2095190"/>
<dbReference type="ChEMBL" id="CHEMBL2111339"/>
<dbReference type="ChEMBL" id="CHEMBL2111366"/>
<dbReference type="ChEMBL" id="CHEMBL2111370"/>
<dbReference type="ChEMBL" id="CHEMBL2111392"/>
<dbReference type="ChEMBL" id="CHEMBL2111413"/>
<dbReference type="DrugBank" id="DB00659">
<property type="generic name" value="Acamprosate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00546">
<property type="generic name" value="Adinazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB06579">
<property type="generic name" value="Adipiplon"/>
</dbReference>
<dbReference type="DrugBank" id="DB00404">
<property type="generic name" value="Alprazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00543">
<property type="generic name" value="Amoxapine"/>
</dbReference>
<dbReference type="DrugBank" id="DB11901">
<property type="generic name" value="Apalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB11859">
<property type="generic name" value="Brexanolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01558">
<property type="generic name" value="Bromazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00237">
<property type="generic name" value="Butabarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00241">
<property type="generic name" value="Butalbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00395">
<property type="generic name" value="Carisoprodol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00475">
<property type="generic name" value="Chlordiazepoxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01594">
<property type="generic name" value="Cinolazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00349">
<property type="generic name" value="Clobazam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01068">
<property type="generic name" value="Clonazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00628">
<property type="generic name" value="Clorazepic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01559">
<property type="generic name" value="Clotiazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01189">
<property type="generic name" value="Desflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00829">
<property type="generic name" value="Diazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00228">
<property type="generic name" value="Enflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB01215">
<property type="generic name" value="Estazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00402">
<property type="generic name" value="Eszopiclone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00189">
<property type="generic name" value="Ethchlorvynol"/>
</dbReference>
<dbReference type="DrugBank" id="DB09166">
<property type="generic name" value="Etizolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00292">
<property type="generic name" value="Etomidate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01567">
<property type="generic name" value="Fludiazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01205">
<property type="generic name" value="Flumazenil"/>
</dbReference>
<dbReference type="DrugBank" id="DB01544">
<property type="generic name" value="Flunitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00690">
<property type="generic name" value="Flurazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01381">
<property type="generic name" value="Ginkgo biloba"/>
</dbReference>
<dbReference type="DrugBank" id="DB01437">
<property type="generic name" value="Glutethimide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00801">
<property type="generic name" value="Halazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01159">
<property type="generic name" value="Halothane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00753">
<property type="generic name" value="Isoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00555">
<property type="generic name" value="Lamotrigine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00186">
<property type="generic name" value="Lorazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB13872">
<property type="generic name" value="Lormetazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00603">
<property type="generic name" value="Medroxyprogesterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01043">
<property type="generic name" value="Memantine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00371">
<property type="generic name" value="Meprobamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00463">
<property type="generic name" value="Metharbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01028">
<property type="generic name" value="Methoxyflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB01107">
<property type="generic name" value="Methyprylon"/>
</dbReference>
<dbReference type="DrugBank" id="DB15489">
<property type="generic name" value="Mexazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB12458">
<property type="generic name" value="Muscimol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01595">
<property type="generic name" value="Nitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00334">
<property type="generic name" value="Olanzapine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00842">
<property type="generic name" value="Oxazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00312">
<property type="generic name" value="Pentobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00252">
<property type="generic name" value="Phenytoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01588">
<property type="generic name" value="Prazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00794">
<property type="generic name" value="Primidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00818">
<property type="generic name" value="Propofol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01589">
<property type="generic name" value="Quazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01236">
<property type="generic name" value="Sevoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB09118">
<property type="generic name" value="Stiripentol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00306">
<property type="generic name" value="Talbutal"/>
</dbReference>
<dbReference type="DrugBank" id="DB01956">
<property type="generic name" value="Taurine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00231">
<property type="generic name" value="Temazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB11582">
<property type="generic name" value="Thiocolchicoside"/>
</dbReference>
<dbReference type="DrugBank" id="DB00897">
<property type="generic name" value="Triazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00425">
<property type="generic name" value="Zolpidem"/>
</dbReference>
<dbReference type="DrugCentral" id="P18507"/>
<dbReference type="TCDB" id="1.A.9.5.4">
<property type="family name" value="the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family"/>
</dbReference>
<dbReference type="GlyGen" id="P18507">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P18507"/>
<dbReference type="PhosphoSitePlus" id="P18507"/>
<dbReference type="SwissPalm" id="P18507"/>
<dbReference type="BioMuta" id="GABRG2"/>
<dbReference type="DMDM" id="116242488"/>
<dbReference type="EPD" id="P18507"/>
<dbReference type="MassIVE" id="P18507"/>
<dbReference type="PeptideAtlas" id="P18507"/>
<dbReference type="PRIDE" id="P18507"/>
<dbReference type="ProteomicsDB" id="27833"/>
<dbReference type="ProteomicsDB" id="53569">
<molecule id="P18507-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53570">
<molecule id="P18507-2"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P18507-2">
<molecule id="P18507-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="28585">
<property type="antibodies" value="377 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000414552">
<molecule id="P18507-3"/>
<property type="protein sequence ID" value="ENSP00000410732"/>
<property type="gene ID" value="ENSG00000113327"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000639111">
<molecule id="P18507-2"/>
<property type="protein sequence ID" value="ENSP00000492125"/>
<property type="gene ID" value="ENSG00000113327"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000639213">
<molecule id="P18507-1"/>
<property type="protein sequence ID" value="ENSP00000491909"/>
<property type="gene ID" value="ENSG00000113327"/>
</dbReference>
<dbReference type="GeneID" id="2566"/>
<dbReference type="KEGG" id="hsa:2566"/>
<dbReference type="UCSC" id="uc003lyy.5">
<molecule id="P18507-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2566"/>
<dbReference type="DisGeNET" id="2566"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000113327.14"/>
<dbReference type="GeneCards" id="GABRG2"/>
<dbReference type="HGNC" id="HGNC:4087">
<property type="gene designation" value="GABRG2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000113327">
<property type="expression patterns" value="Tissue enriched (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="GABRG2"/>
<dbReference type="MIM" id="137164">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="604233">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607681">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="618396">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P18507"/>
<dbReference type="OpenTargets" id="ENSG00000113327"/>
<dbReference type="Orphanet" id="64280">
<property type="disease" value="Childhood absence epilepsy"/>
</dbReference>
<dbReference type="Orphanet" id="33069">
<property type="disease" value="Dravet syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="36387">
<property type="disease" value="Generalized epilepsy with febrile seizures-plus"/>
</dbReference>
<dbReference type="Orphanet" id="1945">
<property type="disease" value="Rolandic epilepsy"/>
</dbReference>
<dbReference type="Orphanet" id="442835">
<property type="disease" value="Undetermined early-onset epileptic encephalopathy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28501"/>
<dbReference type="eggNOG" id="KOG3642">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156685"/>
<dbReference type="HOGENOM" id="CLU_010920_2_0_1"/>
<dbReference type="InParanoid" id="P18507"/>
<dbReference type="KO" id="K05186"/>
<dbReference type="OMA" id="AQAGMCS"/>
<dbReference type="OrthoDB" id="1057372at2759"/>
<dbReference type="PhylomeDB" id="P18507"/>
<dbReference type="TreeFam" id="TF315453"/>
<dbReference type="PathwayCommons" id="P18507"/>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977443">
<property type="pathway name" value="GABA receptor activation"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="2566">
<property type="hits" value="6 hits in 871 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GABRG2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="GABRG2"/>
<dbReference type="GenomeRNAi" id="2566"/>
<dbReference type="Pharos" id="P18507">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P18507"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P18507">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000113327">
<property type="expression patterns" value="Expressed in middle temporal gyrus and 119 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P18507">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P18507">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034707">
<property type="term" value="C:chloride channel complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030659">
<property type="term" value="C:cytoplasmic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0032590">
<property type="term" value="C:dendrite membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902711">
<property type="term" value="C:GABA-A receptor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0098794">
<property type="term" value="C:postsynapse"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008503">
<property type="term" value="F:benzodiazepine receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005254">
<property type="term" value="F:chloride channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004890">
<property type="term" value="F:GABA-A receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0022851">
<property type="term" value="F:GABA-gated chloride ion channel activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005237">
<property type="term" value="F:inhibitory extracellular ligand-gated ion channel activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030594">
<property type="term" value="F:neurotransmitter receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1904315">
<property type="term" value="F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030534">
<property type="term" value="P:adult behavior"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071420">
<property type="term" value="P:cellular response to histamine"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007268">
<property type="term" value="P:chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902476">
<property type="term" value="P:chloride transmembrane transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007214">
<property type="term" value="P:gamma-aminobutyric acid signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1904862">
<property type="term" value="P:inhibitory synapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034220">
<property type="term" value="P:ion transmembrane transport"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050877">
<property type="term" value="P:nervous system process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042391">
<property type="term" value="P:regulation of membrane potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060078">
<property type="term" value="P:regulation of postsynaptic membrane potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051932">
<property type="term" value="P:synaptic transmission, GABAergic"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="2.70.170.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR006028">
<property type="entry name" value="GABAA/Glycine_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR005439">
<property type="entry name" value="GABBAg2_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR005437">
<property type="entry name" value="GABBAg_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR006202">
<property type="entry name" value="Neur_chan_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036734">
<property type="entry name" value="Neur_chan_lig-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006201">
<property type="entry name" value="Neur_channel"/>
</dbReference>
<dbReference type="InterPro" id="IPR036719">
<property type="entry name" value="Neuro-gated_channel_TM_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006029">
<property type="entry name" value="Neurotrans-gated_channel_TM"/>
</dbReference>
<dbReference type="InterPro" id="IPR018000">
<property type="entry name" value="Neurotransmitter_ion_chnl_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR18945">
<property type="entry name" value="PTHR18945"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02931">
<property type="entry name" value="Neur_chan_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02932">
<property type="entry name" value="Neur_chan_memb"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00253">
<property type="entry name" value="GABAARECEPTR"/>
</dbReference>
<dbReference type="PRINTS" id="PR01620">
<property type="entry name" value="GABAARGAMMA"/>
</dbReference>
<dbReference type="PRINTS" id="PR01622">
<property type="entry name" value="GABAARGAMMA2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00252">
<property type="entry name" value="NRIONCHANNEL"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF63712">
<property type="entry name" value="SSF63712"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF90112">
<property type="entry name" value="SSF90112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00860">
<property type="entry name" value="LIC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00236">
<property type="entry name" value="NEUROTR_ION_CHANNEL"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0868">Chloride</keyword>
<keyword id="KW-0869">Chloride channel</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="signal peptide" evidence="9">
<location>
<begin position="1"/>
<end position="39"/>
</location>
</feature>
<feature type="chain" description="Gamma-aminobutyric acid receptor subunit gamma-2" id="PRO_0000000477">
<location>
<begin position="40"/>
<end position="467"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="25">
<location>
<begin position="40"/>
<end position="273"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="25">
<location>
<begin position="274"/>
<end position="296"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="25">
<location>
<begin position="300"/>
<end position="322"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="25">
<location>
<begin position="334"/>
<end position="356"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="25">
<location>
<begin position="357"/>
<end position="443"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="25">
<location>
<begin position="444"/>
<end position="466"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with GABARAP" evidence="9">
<location>
<begin position="425"/>
<end position="442"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9">
<location>
<position position="52"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9">
<location>
<position position="129"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9">
<location>
<position position="247"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="190"/>
<end position="204"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_047323" evidence="25">
<original>Y</original>
<variation>WSRSIAQAGMCSGVISAHYSLRFWGSTDPPTLASRVAGISD</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_041124" evidence="24">
<original>P</original>
<variation>PLLRMFSFK</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with generalized tonic-clonic seizures; dbSNP:rs112894280." id="VAR_065226" evidence="14">
<original>N</original>
<variation>S</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In ECA2 and FEB8; abolishes in vitro sensitivity to diazepam; dbSNP:rs121909673." id="VAR_014265" evidence="11">
<original>R</original>
<variation>Q</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with idiopathic generalized epilepsy; unknown pathological significance; the currents elicited by mutant receptors are indistinguishable from wild-type; no difference in sensitivity of the mutant receptors to the allosteric regulators zinc and benzodiazepine diazepam compared to wild-type; dbSNP:rs587777365." id="VAR_071813" evidence="15">
<original>P</original>
<variation>S</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE74; does not affect protein abundance; decreases cell surface expression; decreases current amplitude in response to GABA; does not affect zinc sensitivity; accelerates activation and prolonges deactivation; dbSNP:rs796052505." id="VAR_082266" evidence="20">
<original>A</original>
<variation>T</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE74; increases protein abundance; retained in the endoplasmic reticulum; decreases cell surface expression; decreases current amplitude in response to GABA; increases zinc sensitivity; accelerates activation and prolonges deactivation." id="VAR_082267" evidence="20">
<original>I</original>
<variation>T</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In FEB8; dbSNP:rs267606837." id="VAR_038602" evidence="13">
<original>R</original>
<variation>G</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with generalized epilepsy with myoclonic atonic seizures, cognitive impairment and behavioral disorder." id="VAR_078226" evidence="21">
<original>Y</original>
<variation>C</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE74; increases protein abundance; retained in the endoplasmic reticulum decreases; cell surface expression; decreases current amplitude in response to GABA; increases zinc sensitivity; accelerates activation and prolonges deactivation; dbSNP:rs796052508." id="VAR_082268" evidence="20">
<original>P</original>
<variation>S</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In GEFS+3 and EIEE74; does not affect protein abundance; decreases cell surface expression; decreases current amplitude in response to GABA; increases zinc sensitivity; accelerates deactivation; dbSNP:rs397514737." id="VAR_078620" evidence="16 20">
<original>R</original>
<variation>Q</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE74; does not affect protein abundance; decreases cell surface expression; decreases current amplitude in response to GABA; increases zinc sensitivity; accelerates deactivation; dbSNP:rs796052510." id="VAR_082269" evidence="20">
<original>R</original>
<variation>W</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In GEFS+3; dbSNP:rs121909672." id="VAR_014266" evidence="10">
<original>K</original>
<variation>M</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE74; does not affect protein abundance; decreases cell surface expression; decreases current amplitude in response to GABA; does not affect zinc sensitivity; accelerates activation and prolonges deactivation; dbSNP:rs796052511 and dbSNP:rs1554100923." id="VAR_082270" evidence="20">
<original>F</original>
<variation>L</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17855003." id="VAR_065163" evidence="12">
<original>H</original>
<variation>R</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA33437." ref="1" evidence="25">
<original>T</original>
<variation>M</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA33437." ref="1" evidence="25">
<original>T</original>
<variation>S</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="25">
<location>
<begin position="384"/>
<end position="385"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="25">
<original>E</original>
<variation>D</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="25">
<original>IA</original>
<variation>RI</variation>
<location>
<begin position="438"/>
<end position="439"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="66"/>
<end position="74"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="83"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="90"/>
<end position="101"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="106"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="110"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="134"/>
<end position="137"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="139"/>
<end position="144"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="150"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="155"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="168"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="176"/>
<end position="189"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="195"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="202"/>
<end position="212"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="215"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="218"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="232"/>
<end position="235"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="238"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="258"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="273"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="280"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="291"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="301"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="321"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="324"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="334"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="441"/>
<end position="463"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6D6T"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6D6U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HUG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6HUJ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6I53"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250"/>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P18508"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P22723"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11326274"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11326275"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16924025"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20485450"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21714819"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23708187"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23909897"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2538761"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25489750"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27864268"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27864847"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29950725"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9892355"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="467" mass="54162" checksum="7450DFE1157C9224" modified="2006-10-17" version="2" precursor="true">MSSPNIWSTGSSVYSTPVFSQKMTVWILLLLSLYPGFTSQKSDDDYEDYASNKTWVLTPKVPEGDVTVILNNLLEGYDNKLRPDIGVKPTLIHTDMYVNSIGPVNAINMEYTIDIFFAQTWYDRRLKFNSTIKVLRLNSNMVGKIWIPDTFFRNSKKADAHWITTPNRMLRIWNDGRVLYTLRLTIDAECQLQLHNFPMDEHSCPLEFSSYGYPREEIVYQWKRSSVEVGDTRSWRLYQFSFVGLRNTTEVVKTTSGDYVVMSVYFDLSRRMGYFTIQTYIPCTLIVVLSWVSFWINKDAVPARTSLGITTVLTMTTLSTIARKSLPKVSYVTAMDLFVSVCFIFVFSALVEYGTLHYFVSNRKPSKDKDKKKKNPAPTIDIRPRSATIQMNNATHLQERDEEYGYECLDGKDCASFFCCFEDCRTGAWRHGRIHIRIAKMDSYARIFFPTAFCLFNLVYWVSYLYL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

